Mr. Cordani’s stock potential and stock options totaled $8.4 million, putting his overall compensation at roughly $21 million, according to the report.
Of the $12.5 million excluding future stock options, Mr. Cordani had a base salary of $1 million, exercised stock options of $2 million, non-equity incentives of $9.3 million and $130,494 in “other compensation.”
In February, Cigna reported net income of $290 million in the fourth quarter of fiscal year 2011, down 37 percent from the same quarter of 2010. For the entire 2011 fiscal year, Cigna recorded a profit of $1.33 billion, slightly down from the $1.35 billion recorded in FY 2010.
More Articles on Cigna:
Cigna Website Will Show Prices of More Than 200 Hospital Procedures
Cigna Completes HealthSpring Acquisition
Cigna Launches Accountable Care Program With Weill Cornell Physicians
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
